Merck KGaA (MRKd)

CBOE (Germany)Healthcare

€124.3
-€1.65 (-1.3%)
Last close

January 21, 2026 at 16:30 UTC

Interactive Chart
MRKd
1H
3H
6H
12H
1D
1W
1M
3M
6M
12M (YTD)
2Y
5Y
All
About Merck KGaA

Name

Merck KGaA

CEO

Belen Garijo Lopez

Industry

Healthcare

Year Founded

1668

Employees

59,020

Merck KGaA is a science and technology company active in life science tools, healthcare, and advanced materials. The unifying idea is method: design processes that researchers, clinicians, and manufacturers can repeat with confidence, then supply the instruments, reagents, therapies, and specialty materials that keep those processes on plan. In laboratories, the brand is associated with clean documentation and support that respects how experiments actually run. In healthcare, development and medical guidance focus on safe use in real clinics, not only in papers. In electronics, materials are delivered with traceability that device makers can audit. Country teams adapt to local rules while holding to common standards. Within the healthcare and technology ecosystem, the group presents itself as infrastructure for discovery and production, linking disciplined science with delivery that works on busy days as well as calm ones.

Analyst Ratings
Consensus Recommendation
Analyst consensus: 11 Buy, 8 Hold, 5 Sell
Buy11
Hold8
Sell5
Fundamentals & Financials
Revenue (TTM)
€21.2B
Net Income (TTM)
€2.9B
EPS (TTM)
€6.79
ROA (TTM)
5.8%
Current Ratio
1.49
Dividend Yield
0.1%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement (Quarterly)
ItemQ3 2025
Revenue€5,318M
Cost of Sales€2,105M
Gross Profit€3,213M
Operating Income€1,221M
Net Income€902,000K
EPS€2.07
Technical Indicators

Merck KGaA's Technical Indicators Summary

MRKd is currently trading just below key short-term moving averages, with the price slightly under the 10-day SMA and EMA, which signal caution, while remaining above longer-term averages that indicate underlying strength. Momentum indicators like RSI and CCI suggest a balanced market with moderate buying pressure, and the MACD level supports this neutral view. The ADX reading points to a fairly strong trend, yet the price’s position near the VWAP and classic pivot level—both acting as resistance—limits upward momentum. Meanwhile, moderate volatility and a positive on-balance volume hint at steady participation without extreme swings. Overall, the technical landscape reflects equilibrium between bulls and bears, resulting in a neutral stance.

Buy
11 signals
Neutral
8 signals
Sell
5 signals
Overall: Neutral33% Neutral signals
IndicatorValue
RSI (14)
56.76
Stochastic %K (14, 3, 3)
72.05
CCI (20)
37.92
WPR (14)
-46.79
Momentum (10)
0.15
MFI
66.47
MACD Level (12, 26)
2.85
Bollinger Bands
$116.70 - $133.14
ATR (14)
$2.44 (1.93%)
ADX (14)
42.32
OBV
-3,372,547
VWAP
$127.36
Classic Pivot Point
$128.55
Fibonacci Pivot Point
$128.55
Simple Moving Averages
$114.82 - $128.49(5 indicators)
Exponential Moving Averages
$118.31 - $127.55(5 indicators)
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.

Today's Snapshot

Opening trade leaned mildly bullish, with MRK.DE opening 0.518% above 125.55 at 126.20. The day starts with sector performance largely flat (-0.22%), keeping the backdrop balanced. Limited sector movement and no recent news suggest MRK.DE's early gains are driven by overall market stability.

Price Change

from €125.55 close

€-1.2

Trading Volume

Below avg (331.6K)

38K

vs S&P 500 Today

Outperforming Market

+0.86%

52-Week Position

Mid-range

43.8%

Updated: January 21, 2026 at 10:06 UTC

Quote Summary
OpenPrevious Close
€126.2€125.55
Day Range52 Week Range
€123.45 - €126.4€100.7 - €154.65
VolumeAvg. Volume
303.1K259.2K
Market CapP/E Ratio
€53.9B18.3